Title：SLCO2B1 and SLCO1B3 are pharmacogenomic determinants of resistance to androgen deprivation therapy for prostate cancer.

Reporter: Ming Yang

Department of Medical Oncology

Dana-Farber Cancer Institute and Harvard Medical School

Host: Jun Yu

Time：2:00 pm.-3:30 pm. On Jan.7, 2010

Location：Conference room 202, Beijing Institute of Genomics，CAS 

 

 

－－－－－－－－－－－－－－－－－－

Welcome to attend!